BioSpace News Archive

Drug Development

Luye Pharma’s Goserelin Acetate Extended-release Microspheres Start Phase III Clinical Trials in China, Paralleling Smooth Progress with U.S. Regulators

Luye Pharma announced that its independently developed drug, Goserelin Acetate Extended-release Microspheres for Injection (LY01005), has entered phase III clinical trials for prostate cancer in China.

September 7, 2018
·
4 min read
Lone Star Bio

A New Take on Fighting Multi-Drug Resistant Bacteria

UH Researchers Receive $3.5 M to Find Best Combinations of Antibiotics

September 7, 2018
·
3 min read
FDA

FDA clears development path for BTX 1204

Botanix held a Pre-IND Meeting with the FDA for the BTX 1204 atopic dermatitis product

September 7, 2018
·
1 min read
Deals

SOTIO and PPF Complete Acquisition of Cytune Pharma

SOTIO announces today the completion of the acquisition of Cytune Pharma by PPF. SOTIO will continue to develop the lead program SO-C101 (RLI-15) within its pipeline and intends to initiate first-in-human clinical trials in early 2019.

September 7, 2018
·
4 min read
Business

EVOTEC AND CHDI FOUNDATION EXTEND ONGOING COLLABORATION TO FIGHT HUNTINGTON’S DISEASE

Evotec AG today announced that CHDI Foundation, Inc. (“CHDI”) has extended its collaboration with Evotec through to 2023. Over this period, CHDI may fund up to 75 full-time scientists at Evotec.

September 7, 2018
·
5 min read
Drug Development

Botanix Pharmaceuticals Preliminary Final Report

Successfully completed the BTX 1530 Phase 1b acne patient and advanced into Phase 2 clinical development in June 2108

September 7, 2018
·
1 min read
Global Brain Implants Market 2018-2022 | Adoption of Robot-assisted Implantation to Boost Demand | Technavio

The global brain implants market 2018-2022 is expected to post a CAGR of more than 7% during the forecast period, according to the latest market research report by Technavio.

September 7, 2018
·
4 min read
Biotech Bay

German Health Technology Assessment Body (IQWiG) Concludes Only Oncotype DX® has Sufficient Evidence to Guide Breast Cancer Adjuvant Chemotherapy Decisions Based on Landmark TAILORx Study Results

Genomic Health, Inc., (NASDAQ: GHDX) today announced the publication of an updated assessment of breast cancer gene expression profiling tests by the German Institute for Quality and Efficiency in Health Care (IQWiG)

September 7, 2018
·
5 min read
Business

Emily Leproust, Ph.D., Recognized as 2018 Upstart 50

Emily Leproust, Ph.D., CEO of Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA, has been recognized as an honoree of the 2018 Upstart 50.

September 7, 2018
·
2 min read
Biotech Bay

Exelixis Announces New Recommendations for CABOMETYX® (Cabozantinib) Tablets in Updated National Comprehensive Cancer Network Clinical Practice Guidelines

Exelixis, Inc. (NASDAQ:EXEL) today announced that the National Comprehensive Cancer Network (NCCN) updated its Clinical Practice Guidelines to include new recommendations for CABOMETYX® (cabozantinib) tablets.

September 7, 2018
·
13 min read